Does Treating Hookworm Improve Productivity of Small Subsistence Farmers

NCT02102321 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 300

Last updated 2014-04-02

No results posted yet for this study

Summary

Treatment of hookworm infected groups with albendazole has been shown to result in an increase in hemoglobin levels and a related decrease in the prevalence of anemia. Increases in hemoglobin levels due to treatment have been associated with significant gains in adult labor productivity.

In this study, the investigators hypothesize that regular treatment of women smallholder farmers in a high prevalence area with the anti-hookworm drug albendazole and iron supplementation will improve hookworm associated anemia. Further, regular treatment of albendazole and iron supplementation will improve their work capacity when compared to a control group

Conditions

  • Hookworm Stool Burden
  • Anemia
  • Exercise Tolerance

Interventions

DRUG

albendazole

DRUG

placebo

Sponsors & Collaborators

  • Akeso Associates

    collaborator UNKNOWN
  • Bill and Melinda Gates Foundation

    collaborator OTHER
  • Eastern Congo Initiative

    collaborator UNKNOWN
  • HEAL Hospital, DRC

    collaborator UNKNOWN
  • Salmon, Margaret, M.D.

    lead INDIV

Principal Investigators

  • Margaret Salmon, MD MPH · University Health Network, Toronto

  • Christian Salmon, DrSc · Western New England University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
SINGLE_GROUP

Eligibility

Min Age
17 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-03-31
Primary Completion
2015-08-31
Completion
2015-08-31

Countries

  • Republic of the Congo

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02102321 on ClinicalTrials.gov